Entry requirements: 150 credits including 90 credits in pharmaceutical science, cell biology, biotechnology, physiology, biomedicine, chemistry and/or biology or the equivalent, and at least 7.5 credits in biologics. Proficiency in English equivalent to the general entry requirements for first-cycle (Bachelor's level) studies.
If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application or tuition fees. Formal exchange students will be exempted from tuition fees, as well as the application fee. Read more about fees.
Application fee: SEK 900
Tuition fee, first semester:
Tuition fee, total:
About the course
Through the course, you will gain an understanding of how to further develop a protein based biological drug after the initial proposed design of the drug. You will work on designing experiments to analyse if the biological drug has the predicted effect as well as in-depth formulate which indication you should treat and which diagnostic tools can be used to find the right patient group. They will also develop a target products profile (TPP) for the drug candidate and based on this formulate a quality TPP. With this base, they will learn more about analytical tools that can be used during the process development of a drug and also gain an understanding of how the drug and/or its effects can be measured in biological samples by e.g. mass spectrometry.